TMEM106B Supports Viral Entry and Syncytia Formation Mediated by the Spike Proteins From Omicron BA.2.86 and JN.1
Journal of Medical Virology · 2025
DOI: 10.1002/jmv.70439 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2025. Verfasst von Yuanyuan Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing,…. Hauptthemen laut MEDLINE: Virus Internalization, Spike Glycoprotein, Coronavirus, SARS-CoV-2, COVID-19. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: This study was supported by the National Key Research and Development Program (2023YFC2306000) and the National Key Research and Development Program (2023YFC30….
Abstract (Originalsprache)
Transmembrane protein 106B (TMEM106B) has been identified as a functional receptor facilitating ACE2‐independent SARS‐CoV‐2 entry. However, its role in supporting a broad range of SARS‐CoV‐2 variants, including the emerging Omicron BA.2.86 and JN.1 subvariants, remains to be determined. To address this question, we generated 293‐ and A549‐derived TMEM106B knockout cell lines and assessed their ability to support viral entry for various SARS‐CoV‐2 variants (D614G, E484D, Omicron BA.1, BA.2, XBB.1.5, BA.2.86, and JN.1) using pseudoviral infection systems. We also examined the role of transmembrane protease serine 2 (TMPRSS2) and other type II transmembrane serine proteases (TTSP) in viral entry and syncytium formation. Our results showed that TMEM106B knockout significantly reduced viral entry across all tested variants. Additionally, overexpression of TMPRSS2, TMPRSS11F and TMPRSS13 in TMEM106B‐expressing cells enhanced viral entry and syncytium formation, including BA.2.86 and JN.1 variants. Importantly, we identified two single‐nucleotide polymorphisms (SNPs) that result in G2A and N151S variant, respectively, affects TMEM106B receptor function, indicating that selected genetic polymorphisms of TMEM106B gene may impact cell susceptibility to SARS‐CoV‐2 infection. These findings highlight TMEM106B as a functional receptor for SARS‐CoV‐2 across different variants, including the latest Omicron subvariants, and provide new insights for the therapeutic interventions targeting viral entry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
- Beijing Key Laboratory of Viral Infectious Disease, Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
- Beijing Institute of Infectious Diseases, Beijing, China.
- National Center for Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
- Peking University Ditan Teaching Hospital, Beijing, China.
ORCID-Profile: Xuesen Zhao
Förderung
- This study was supported by the National Key Research and Development Program (2023YFC2306000) and the National Key Research and Development Program (2023YFC30…
Zitieren
APA
Wang, Y., Sun, H., Liu, Y., Song, Y., Wang, W., Li, G., Zhang, J., Zhang, Y., Chen, D., & Zhao, X. (2025). TMEM106B Supports Viral Entry and Syncytia Formation Mediated by the Spike Proteins From Omicron BA.2.86 and JN.1. Journal of Medical Virology. https://doi.org/10.1002/jmv.70439
Vancouver
Wang Y, Sun H, Liu Y, Song Y, Wang W, Li G, et al. TMEM106B Supports Viral Entry and Syncytia Formation Mediated by the Spike Proteins From Omicron BA.2.86 and JN.1. Journal of Medical Virology. 2025. doi:10.1002/jmv.70439
BibTeX
@article{Wang2025,
author = {Wang, Yuanyuan and Sun, Hui and Liu, Yuxin and Song, Yanjun and Wang, Weitong and Li, Guoli and Zhang, Jie and Zhang, Yuanyuan and Chen, Danying and Zhao, Xuesen},
title = {TMEM106B Supports Viral Entry and Syncytia Formation Mediated by the Spike Proteins From Omicron BA.2.86 and JN.1},
journal = {Journal of Medical Virology},
year = {2025},
doi = {10.1002/jmv.70439}
}
EUVIMED